FDA expands approval of breast cancer drug Kisqali
Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm
Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the company recently received an extended approval for it from the U.S. Food and Drug Administration.
FDA expands use of Kisqali to early stage breast cancer patients
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
FDA awards Novartis expanded approval for breast cancer therapy
The potential market for the Novartis drug Kisqali could grow markedly, now that certain early-stage breast cancer patients will be able to receive it.
Novartis Wins FDA Approval of Kisqali for Early Breast Cancer
Novartis NVS announced that the FDA has approved breast cancer drug Kisqali (ribociclib) for a broader population. The regulatory body approved Kisqali in combination with an aromatase inhibitor (AI) for the adjuvant treatment of people with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer (EBC) at high risk of recurrence,
FDA expands approval for drug to treat early-stage breast cancer
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. NBC News' Kathy Park speaks to a woman who took the drug while it was in clinical trials and is now cancer free.
Merck wins 1st FDA approval for Keytruda
FDA to investigate metals found in tampons after study; study's co-author 'excited' over probe
The FDA will now investigate metals found in tampons following the results of a recent study. The study's co-author weighs in ...
The FDA wants to place warning labels on food packages to combat obesity and other health conditions
Front-of-package labels hope to fight rising obesity rates and reduce the prevalence of other health conditions, like ...
Elon Musk’s Neuralink brain chip receives FDA’s ‘breakthrough device’ status — and could help blind people see again
Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind ...
FDA to propose new food label warnings to combat obesity
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
Food Safety News2d
FDA warns food companies for violations in acidified foods and seafood imports
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
Elon Musk's brain-chip startup Neuralink said on Tuesday its implant had received the U.S. Food and Drug Administration's ...
Agri-Pulse11h
Food safety advocates push FDA for limit on lead in spices
More than a dozen ground cinnamon products have been recalled over the last year, after the Food and Drug Administration boosted efforts ... to ensure their product has safe levels. This year ...
Investopedia8d
Food and Drug Administration (FDA): What It Is and Does
Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...
Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data
For CNM-Au8, Clene has more than 700 patient-years of safety data that show no significant safety concerns or safety trends identified. No serious adverse events (SAEs) have been identified as related ...